لوثيماكس
salomon,levin & elstein ltd - loteprednol etabonate 5 mg / 1 ml - ophthalmic suspension - loteprednol - lotemax is indicated for the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitides, when the inherent hazard of steroid use is accepted to otain an advisable diminution in edema and inflammation. lotemax is less effective than prednisolone acetate 1 % in two 28 day controlled clinical studies in acute anterior uveitis, where 72 % of patients treated with lotemax experienced resolution of anterior chamber cells, compared to 87 % of patients treated with prednisolone acetate 1 % . the incidence of patients with clinically significant increases in iop (> or = 10 mmhg) was 1 % with lotemax adn 6 % with prednisolone acetate 1 %. lotemax should not be used in patients who require a more potent corticosteroid for this indication. lotemax is also indicated for the treatment of po
lamotrigina tevagen 100mg 56 comprim dispers efg
lamotrigina tevagen 200mg 30 comprim dispersab efg
lamotrigina tevagen 50mg 56 comprim dispersa efg
ebastina tevagen 10mg 20 comprimidos recubiertos pelicula efg
ebastina tevagen 20mg 20 comprimidos recubiertos pelicula efg
gabapentina tevagen 300mg 90 capsulas efg
gabapentina tevagen 400mg 90 capsulas efg
aceclofenaco tevagen 100mg 20 comprimidos recubiertos pelic efg